Immatics Competitors and Similar CompaniesClear all
Immatics's competitors and similar companies include Eureka Therapeutics, Tessa Therapeutics, Juno Therapeutics and CaroGen.
 Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. |  Eureka Therapeutics Eureka Therapeutics is a biotechnology company focused on discovery of novel antibody immunotherapies for the treatment of cancer.
|  Tessa Therapeutics Tessa Therapeutics is a clinical-stage biotechnology company focused on the cancer treatment development. |  Juno Therapeutics Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer. | ||
Founding Date | Founding Date N/A | Founding Date 2006 | Founding Date 2011 | Founding Date 2013 | Founding Date 2012 |
Type | Type Public | Type Private | Type Private | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations Emeryville, US HQ | Locations Singapore, SG HQ | Locations Seattle, US HQ Göttingen, DE Göttingen, DE München, DE München, DE Bothell, US Brisbane, US | Locations Farmington, US HQ |
Employees | Employees 24215% increase | Employees 46 | Employees 452% decrease | Employees 1173% increase | Employees 12 |
Financial | |||||
Revenue (est.) | Revenue (est.) €54m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $111.9m (FY, 2017) | Revenue (est.) N/A |
Net income | Net income (€97m) (FY, 2023) | Net income N/A | Net income N/A | Net income ($437.1m) (FY, 2017) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 45m (about 5 years ago) | Latest funding round $ 80m (over 7 years ago) | Latest funding round N/A | Latest funding round $ 1.4m (about 6 years ago) |
Total funding raised | Total funding raised $ 267.3m | Total funding raised $ 130.4m | Total funding raised $ 80m | Total funding raised $ 310m | Total funding raised $ 1.6m |
For sources of this data, please see the company profile
View Company Profiles
Eureka Therapeutics
HQ
Emeryville, US
Employees
46
Eureka Therapeutics is a biotechnology company focused on discovery of novel antibody immunotherapies for the treatment of cancer.
View companyTessa Therapeutics
HQ
Singapore, SG
Employees
45↓ 2% decrease
Tessa Therapeutics is a clinical-stage biotechnology company focused on the cancer treatment development.
View companyJuno Therapeutics
HQ
Seattle, US
Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
View company
CaroGen
HQ
Farmington, US
Employees
12
CaroGen is a biopharmaceutical company specializing in immunotherapy.
View company